BNGO News and Press, Bionano Genomics Inc. From 02/11/21

SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in a wide variety of solid tumor samples. The study, led by Dr. James Broa...

The University Health Network's Laboratory Medicine Program in Toronto is piloting the Saphyr system from Bionano Genomics (BNGO).The company’s Saphyr system is a research-use-only platform to streamline the study of changes in chromosomes, known as cytogenetics.The Laboratory Medicine...

SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that its Saphyr system is being piloted by the University Health Network's (UHN) Laboratory Medicine Program (LMP) in Toronto. The LMP is the largest hospital diagnostic laboratory in Canada ...

SAN DIEGO, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that presentation recordings from its 5-day Next-Generation Cytogenomics Symposium, which took place from January 11 to 15 and featured 33 presentations by Saphyr users, are now available online on ...

SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today the publication of a study that measured DNA methylation, the chemical modification of the DNA that controls gene regulation, of the various regions regulating cancer genes on single DNA mole...

SAN DIEGO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced a presentation by the Director of the Clinical Cytogenomics Laboratory of Children’s Hospital Los Angeles, Dr. Gordana Raca, in which she reported on the performance of optical genome ma...

At the Festival of Genomics & Biodata, Dr. Alka Chaubey Chief Medical Officer of Bionano Genomics (BNGO) has presented evidence supporting the use of Optical Genome Mapping (“OGM”) with Saphyr as a first-line test in genetic disease and cancer.The company’s Saphyr sys...

SAN DIEGO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced a presentation by Chief Medical Officer Dr. Alka Chaubey at The Festival of Genomics & Biodata where she presented evidence supporting her vision of Optical Genome Mapping (OGM) with Saphyr as a...

You won't find too many hotter stocks on the market right now than Bionano Genomics (NASDAQ: BNGO) . In 2020, shares of the genome analysis company soared 148%. What makes that gain even more impressive is that Bionano was down 55% year to date as of Dec. 22. The stock's remarkable ...

SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the release of version 1.2 of its Compute On Demand (COD) cloud compute solution which significantly reduces the cost and time to analyze structural variants (SVs) in a human genome. This update is ...